Meta-Analysis Confirms Efficacy of Small Molecules for Psoriatic Arthritis
Four small molecule drugs, apremilast, deucravacitinib, tofacitinib, and upadacitinib, exhibited superior efficacy and comparable safety to placebo in patients with active psoriatic arthritis (PsA) in a recent meta-analysis, with deucravacitinib and …